Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, and health technology pioneer DrFirst today announced the launch of a program designed to close gaps in care for patients with chronic health conditions like diabetes and cardiovascular disease while helping health care providers take timely, informed action. The first phase of this novel program aims to increase the use of statin therapy among eligible patients, aligning with a key quality metric from the Centers for Medicare & Medicaid Services (CMS). The use of statins for certain Medicare patients is associated with lower cardiovascular risk, better outcomes and reduced health care costs. To address this, Humana is partnering with DrFirst to connect with prescribers within the clinical workflow. Using the DrFirst prescription orchestration platform, Humana can now initiate new prescription recommendations for these high-risk patients and submit them to the health care provider for consideration. With one click, the provider can approve the prescription recommendation and generate a new prescription or note why it is not an appropriate choice for the patient. \"We're not just flagging care opportunities—we're making sure they get to providers in a way that's timely and easy to act on,\" said Bethanie Stein, Pharm.D., President, Pharmacy at Humana. \"By reaching providers in their workflow, we're freeing them to focus on patient care, which in turn can help address gaps in care, promote quality and lead to better health outcomes.\" The DrFirst prescription orchestration platform is a smart, flexible solution that turns disconnected workflows into real-time clinical collaboration. The rules-based system enables real-time interoperability among health care stakeholders—including health care providers, pharmacies, and payers—to close critical gaps in patient information and collaborate to improve patient outcomes. \"This partnership is about more than innovative technology; it's about better patient outcomes,\" said Laizer Kornwasser, DrFirst CEO. \"As a company dedicated to taking the friction out of health care, it's especially meaningful to introduce an entirely new approach to medication management.\" Because DrFirst e-prescribing technology is used in over 270 EHRs, the prescription orchestration platform can be quickly implemented in workflow across care settings. The collaboration builds on a decade-long track record of innovation between Humana and DrFirst. In 2015, the companies partnered to introduce the first real-time prescription benefit tool, enabling providers to view patient-specific coverage, costs and prior authorization requirements at the point of prescribing.

Humana and DrFirst Partner on Innovation to Fill Gaps in Care, Improve Outcomes for Patients with Diabetes and Other Chronic Conditions

Humana Inc. and health technology company DrFirst have launched a new program to improve care for patients with chronic conditions such as diabetes and cardiovascular disease by integrating prescription recommendations directly into healthcare providers' clinical workflows. The initiative uses DrFirst's prescription orchestration platform to automatically suggest statin therapy for eligible Medicare patients, enabling providers to approve or reject prescriptions with one click. The partnership leverages real-time interoperability between providers, pharmacies, and payers to reduce care gaps and improve patient outcomes. This collaboration builds on a decade of prior partnership between the two companies, which began in 2015 with the introduction of a real-time prescription benefit tool.